Paper30487597
The ERK and JNK pathways in the regulation of metabolic reprogramming.
Papa S and 2 others. Oncogene, 2019. Cited by 312 papers, by iCite.
Cite this record
ConductScience Library. The ERK and JNK pathways in the regulation of metabolic reprogramming. Papers, record 30487597. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30487597
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Transformation, Neoplastic | Major topic |
| Cellular Reprogramming | Major topic |
| Energy Metabolism | Major topic |
| JNK Mitogen-Activated Protein Kinases | Major topic |
| MAP Kinase Signaling System | Major topic |
| Animals | |
| Glycolysis | |
| Humans | |
| Neoplasms |
Source PubMed
References143
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18775299 | Cancer cell metabolism: Warburg and beyond. | Cell | 2008 | https://conductscience.org/library/papers/18775299 | PubMed |
| 2 | 21258394 | Regulation of cancer cell metabolism. | Nat Rev Cancer | 2011 | https://conductscience.org/library/papers/21258394 | PubMed |
| 4 | 5726214 | Early effects of phytohaemagglutinin on glucose metabolism of normal human lymphocytes. | Biochem J | 1968 | https://conductscience.org/library/papers/5726214 | PubMed |
| 5 | 13672205 | The relation between glucose utilization, lactic acid production and utilization and the growth cycle of L strain fibroblasts. | Exp Cell Res | 1959 | https://conductscience.org/library/papers/13672205 | PubMed |
| 6 | 7432468 | Relationship between increased aerobic glycolysis and DNA synthesis initiation studied using glycolytic mutant fibroblasts. | Nature | 1980 | https://conductscience.org/library/papers/7432468 | PubMed |
| 7 | 22231450 | Metabolic reprogramming of the tumor. | Oncogene | 2012 | https://conductscience.org/library/papers/22231450 | PubMed |
| 8 | 15516961 | Why do cancers have high aerobic glycolysis? | Nat Rev Cancer | 2004 | https://conductscience.org/library/papers/15516961 | PubMed |
| 9 | 19861459 | MYC-induced cancer cell energy metabolism and therapeutic opportunities. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19861459 | PubMed |
| 10 | 21127244 | The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. | Science | 2010 | https://conductscience.org/library/papers/21127244 | PubMed |
| 11 | 10551878 | Opposite translational control of GLUT1 and GLUT4 glucose transporter mRNAs in response to insulin. Role of mammalian target of rapamycin, protein kinase b, and phosphatidylinositol 3-kinase in GLUT1 mRNA translation. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10551878 | PubMed |
| 12 | 17301289 | Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. | Mol Biol Cell | 2007 | https://conductscience.org/library/papers/17301289 | PubMed |
| 13 | 18064042 | Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. | Cell Death Differ | 2008 | https://conductscience.org/library/papers/18064042 | PubMed |
| 14 | 11390360 | Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. | Genes Dev | 2001 | https://conductscience.org/library/papers/11390360 | PubMed |
| 15 | 18538731 | Tumor cell metabolism: cancer's Achilles' heel. | Cancer Cell | 2008 | https://conductscience.org/library/papers/18538731 | PubMed |
| 16 | 18775299 | Cancer cell metabolism: Warburg and beyond. | Cell | 2008 | https://conductscience.org/library/papers/18775299 | PubMed |
| 17 | 18046334 | The interplay between MYC and HIF in cancer. | Nat Rev Cancer | 2008 | https://conductscience.org/library/papers/18046334 | PubMed |
| 18 | 19270154 | Tumor suppressors and cell metabolism: a recipe for cancer growth. | Genes Dev | 2009 | https://conductscience.org/library/papers/19270154 | PubMed |
| 19 | 21372320 | Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. | Microbiol Mol Biol Rev | 2011 | https://conductscience.org/library/papers/21372320 | PubMed |
| 20 | 17496909 | Differential regulation and properties of MAPKs. | Oncogene | 2007 | https://conductscience.org/library/papers/17496909 | PubMed |
| 21 | 21982705 | Metabolic flux and the regulation of mammalian cell growth. | Cell Metab | 2011 | https://conductscience.org/library/papers/21982705 | PubMed |
Cited by238
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 312 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42615430 | The Dynamic Alliance of p53 and Metabolism in the Tumor Microenvironment Shapes Tumor Evolution. | Bioessays | 2026 | https://conductscience.org/library/papers/42615430 | PubMed |
| 42587810 | JAK and MEK Pathway Regulation of Mitochondrial Activity as Possible Targets for Saphenous Vein Smooth Muscle Cell Dysfunction in Diabetes. | Cells | 2026 | https://conductscience.org/library/papers/42587810 | PubMed |
| 42582071 | Host systemic metabolism and cancer metabolic vulnerabilities: mechanisms and therapeutic opportunities. | Front Oncol | 2026 | https://conductscience.org/library/papers/42582071 | PubMed |
| 42449980 | Vitamin K2 Promotes Mitochondrial Structural and Functional Homeostasis to Ameliorate Alzheimer Pathology by Targeting the EGFR-Ras-ERK Signaling Axis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42449980 | PubMed |
| 42439660 | Deciphering the Anti-Tumor Mechanisms of Metformin Through Reprogramming of the Tumor Microenvironment. | Cells | 2026 | https://conductscience.org/library/papers/42439660 | PubMed |
| 42397624 | ATP5F1B promotes breast cancer progression through ERK associated metabolic reprogramming. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42397624 | PubMed |
| 42352312 | Unfolding Behavior and Conformational Changes Under Different Denaturing Conditions of MAPK 1 (MEK1). | Biomolecules | 2026 | https://conductscience.org/library/papers/42352312 | PubMed |
| 42248132 | Nitric oxide-driven Warburg reprogramming at the NOS2-COX2 axis: An integrative engine of cancer hallmarks. | Redox Biol | 2026 | https://conductscience.org/library/papers/42248132 | PubMed |
| 42168432 | Simvastatin reprograms lipid metabolism in B16.F10 melanoma cells to favor an early resistant phenotype. | Sci Rep | 2026 | https://conductscience.org/library/papers/42168432 | PubMed |
| 42141314 | Integrative metabolomic and transcriptomic analyses reveal coordinated variation in phenolic acid metabolism and redox-related traits in Ocimum basilicum accessions. | Planta | 2026 | https://conductscience.org/library/papers/42141314 | PubMed |
| 42129337 | Decoding the Raf-Mek-Erk-Rsk pathway in prostate cancer: from molecular mechanisms to clinical opportunities. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42129337 | PubMed |
| 42126497 | Glucose Metabolic Reprogramming in Thyroid Cancer: Underlying Molecular Mechanisms and Links to Progression and Treatment. | Curr Med Sci | 2026 | https://conductscience.org/library/papers/42126497 | PubMed |
| 42123678 | In Vitro Models of Sturge-Weber Syndrome: Strengths, Limitations, and Future Goals. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42123678 | PubMed |
| 42072621 | The N6-Methyladenosine RNA Demethylase AlkB Homolog 5 (ALKBH5) in Metabolic Diseases: Molecular Mechanisms and Pharmacological Implications-A Review. | Biomolecules | 2026 | https://conductscience.org/library/papers/42072621 | PubMed |
| 42005830 | Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/42005830 | PubMed |
| 41913789 | The Crosstalk Between Efferocytosis and Macrophage Polarization in Diabetic Wounds: A Comprehensive Review. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/41913789 | PubMed |
| 41799520 | Circular RNAs: Key Regulators of Tumor Metabolic Reprogramming and Clinical Translation. | Oncol Res | 2026 | https://conductscience.org/library/papers/41799520 | PubMed |
| 41786689 | Absolute dynamic and relative static: the relationship of glycolysis and OXPHOS in cancer development. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/41786689 | PubMed |
| 41692002 | A novel microprotein MUCP1 promotes colorectal cancer metabolic reprogramming by regulating mitochondrial succinate transport. | Neoplasia | 2026 | https://conductscience.org/library/papers/41692002 | PubMed |
| 41662531 | Metabolic stress conditions dictate MAPKAPK2-dependent efficiency of MEK1/2 inhibition in colorectal carcinoma. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41662531 | PubMed |
Genes50
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30487597
GET https://conductscience.org/api/papers/v1/30487597/references?page=2